CPRX - Catalyst Corp Kompaniya qiymatining foyda o‘sish sur’atiga nisbati
Catalyst Pharmaceuticals (CPRX) noyob nevrologiya yo'nalishidagi yetakchiligini saqlab qolmoqda va o'zining asosiy mahsulotidan olingan foydani yangi molekulalarni sotib olishga qayta investitsiya qilmoqda. FDA huquqiy himoyasi va bemorlarning dori vositasiga bog'liqligi raqobatchilarga qarshi mustahkam to'siqni yaratadi. Moslashtirilgan PEG koeffitsiyenti daromadlar ortishining yashirin sekinlashuvi bilan bog'liq xavflar haqida ogohlantiradi, 0.90 qiymati esa ushbu metrikaning joriy darajasini aks ettiradi. Bozor kapitalizatsiyasi Lambert-Eaton miastenik sindromi terapiyasi savdolariga tayanadi.
Catalyst Pharmaceuticals (CPRX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi haqida ma'lumot:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Catalyst Pharmaceuticals|CPRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti catalystpharma.com|CPRX - Kompaniyaning umumiy qarzi|Qarzning balans kapitaliga nisbati Catalyst Pharmaceuticals Inc|CPRX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Catalyst Pharmaceuticals|Kritik likvidlik koeffitsiyenti catalystpharma.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
CPRX - Sof foyda|Kutilayotgan sof daromad Catalyst Pharmaceuticals|CPRX - P/E multiplikatori|Forvard P/E multiplikatori Catalyst Corp|CPRX - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Catalyst Pharmaceuticals Inc|CPRX - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Catalyst Pharmaceuticals|CPRX - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi catalystpharma.com|CPRX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Catalyst Pharmaceuticals
Kompaniyaning jamlanma tahliliyoti:Catalyst Pharma
Catalyst Pharmaceuticals kompaniyasining kam uchraydigan kasalliklar dori vositalari segmentiga kengayishi barqaror foyda o'sishi uchun asos yaratadi, bu esa PEG ko'rsatkichini investitsiya samaradorligini baholash uchun asosiy metrika qiladi. Joriy qiymati 0.90 bo'lgan tarixiy P/E-o'sish tendentsiyasini tahlil qilib, investor bozor ko'paytirgichini foyda o'sish sur'ati bilan solishtiradi: birdan past ko'rsatkich aktivning fundamental salohiyatiga nisbatan qadrsizlanganligidan dalolat beradi.
Catalyst Pharmaceuticals kimlar bilan raqobatlashadi
PEG multiplikatori Biogen Inc (BIIB)|Neurocrine Biosciences Inc - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati RGC (Regencell Corp)|Axsome Therapeutics - PEG multiplikatori|ACAD - PEG multiplikatori|Xenon (XENE) - Narxning foydaga va o‘sish sur’atiga nisbati|VKTX (Viking Therapeutics Inc) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori SUPN|O‘sish sur’atiga tuzatilgan narx-foyda Denali Corp DNLI|Narxning foydaga va o‘sish sur’atiga nisbati Harmony Biosciences (HRMY)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati biohavenpharma.com|Amylyx Pharmaceuticals, Inc. - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati TRVI (Trevi Therapeutics Inc)|PRAX: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti AVXL (Anavex Life Sciences Corp)|CeriBell, Inc. (CBLL) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PRTA (Prothena)|ALEC (Alector Inc.) - PEG multiplikatori|ANNX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori OMER|PEG multiplikatori Neurogene Therapeutics (NGNE)|Narxning foydaga va o‘sish sur’atiga nisbati AC Immune ACIU|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti VYGR|NMRA - Narxning foydaga va o‘sish sur’atiga nisbati|Scilex Holding (SCLX) - Narx-foyda va o‘sish multiplikatori|TVGN: PEG multiplikatori|Alpha Cognition Inc. (ACOG) - PEG multiplikatori|CGTX (Cognition Therapeutics) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori inhibikase.com (IKT)|PEG multiplikatori SAVA|ASRT - O‘sish sur’atiga tuzatilgan narx-foyda|Coya Therapeutics - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori VistaGen Therapeutics, Inc. VTGN|OVID: Narx-foyda va o‘sish multiplikatori|acumenpharm.com - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|CRVO: PEG multiplikatori|ATHE - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|CLNN (Clene Inc) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori PepGen Corp (PEPG)|PEG multiplikatori JUNS|PEG multiplikatori relmada.com (RLMD)|Narxning foydaga va o‘sish sur’atiga nisbati Annovis Bio ANVS|Grace Therapeutics Inc - Narxning foydaga va o‘sish sur’atiga nisbati|AIFF - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Klotho Neurosciences Inc KLTO|NRSN: PEG multiplikatori|Narx-foyda va o‘sish multiplikatori revivapharma.com|Narxning foydaga va o‘sish sur’atiga nisbati MetaVia Inc.|NeurAxis Inc. - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Helius Medical (HSDT)|PASG (passagebio.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Neuphoria Therapeutics - Narx-foyda va o‘sish multiplikatori|NERV: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ATHA - Narxning foydaga va o‘sish sur’atiga nisbati|ADXN (Addex Therapeutics Ltd.) - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|ALZN: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Cyclerion Therapeutics, Inc. (CYCN)|Narx-foyda va o‘sish multiplikatori PTIX|PEG multiplikatori Pasithea|Narxning foydaga va o‘sish sur’atiga nisbati Cortigent, Inc. (CRGT)|ATXI (Avenue Therapeutics Inc.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Cara Therapeutics Inc (CARA) - O‘sish sur’atiga tuzatilgan narx-foyda|Chromocell Therapeutics - PEG multiplikatori|Eliem Therapeutics (ELYM) - Narx-foyda va o‘sish multiplikatori|ITCI: PEG multiplikatori|Longboard Pharmaceuticals Inc (LBPH) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori MRNS|NKGN (NKGen Biotech Corp) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori NRBO|PEG multiplikatori sagerx.com (SAGE)|Narxning foydaga va o‘sish sur’atiga nisbati Synaptogenix SNPX|Trevena Inc. - Narxning foydaga va o‘sish sur’atiga nisbati|VIGL: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Anew Medical Inc.|Cerevel Therapeutics (CERE) - Narxning foydaga va o‘sish sur’atiga nisbati
